Diabetic retinopathy (DR), one of the leading causes of preventable blindness, has been
considered a microcirculatory disease of the retina. However, there is emerging evidence to …

Purpose: To review the usefulness of local and systemic inflammatory biomarkers of diabetic
retinopathy (DR) to implement a more personalized treatment. Methods: An integrated …

OBJECTIVE This study updates previous estimates of the economic burden of diagnosed
diabetes and quantifies the increased health resource use and lost productivity associated …

OBJECTIVE To update estimates of the economic burden of undiagnosed diabetes,
prediabetes, and gestational diabetes mellitus in 2012 in the US and to present state-level …

Objective: To provide an overview of the literature on the burden of diabetic macular edema
(DME) in the United States and selected European countries. Research design and …

Diabetic macular oedema (DMO) is the major cause of visual impairment in people with
diabetes. Optical coherence tomography (OCT) is now the most widely used modality to …

Diabetic retinopathy (DR) remains the leading cause of blindness among working-age
individuals in developed countries. Current treatments for DR are indicated in advanced …

Purpose An important factor in the choice of therapy is the impact it has on the patient's
quality of life. This survey aimed to understand treatment burden, treatment-related anxiety …

OBJECTIVE Direct medical cost of diabetes in the US has been estimated to be 2.3 times
higher relative to individuals without diabetes. This study examines trends in health care …

OBJECTIVE This study updates previous estimates of the economic burden of diagnosed
diabetes, with calculation of the health resource use and indirect costs attributable to …